15 trends tracked about this subject — the full history, oldest to newest below.
Eli Lilly reports that its new combination obesity regimen, EloraTZP, outperformed tirzepatide in a mid-stage clinical trial.
Eli Lilly's experimental triple agonist retatrutide shows substantial weight loss and A1C reduction in new clinical trial data.
New data indicates that the risk of heart failure, kidney disease, or death reaches 55% within ten years following a type 2 diabetes diagnosis.
A massive study shows exercise cuts older adults’ diabetes risk even more sharply, reshaping prevention advice.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Endocrine Society scientific statement shifts obesity treatment focus beyond weight loss to broader health goals.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A world-first clinical trial reveals that statins safely reduce heart attack and stroke risks in healthy adults over the age of 70.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Medical warnings are increasing as data reveals a surge of type 2 diabetes cases among young women, particularly those in their 20s.
Recent studies examine a low-protein longevity diet linked to healthier aging, fat reduction, and natural GLP-1 boosts in mice.